Mast Cell Activation Syndrome (MCAS) Latest Advances
Find the Latest Research About Mast Cell Activation Syndrome (MCAS)
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3959 publications
Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond.
Journal: Expert review of hematology
Published: April 07, 2026
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.
Journal: Immunology and allergy clinics of North America
Published: April 03, 2026
Mast Cell Activation Syndrome and Mimickers.
Journal: Immunology and allergy clinics of North America
Published: April 03, 2026
Management Strategy for Anaphylaxis in a Patient With Suspected or Confirmed Mastocytosis: A Case Report.
Journal: The American journal of case reports
Published: March 22, 2026
Regional disparities in access to epinephrine auto-injectors for children and adults in Italy.
Journal: European annals of allergy and clinical immunology
Published: March 18, 2026
Role of KIT signaling in ovarian development and function: Insights from multisystem biology.
Journal: Biology of reproduction
Published: March 02, 2026
Multiphasic anaphylaxis in the emergency and intensive care setting.
Journal: BMJ case reports
Published: February 26, 2026
Midostaurin-Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis.
Journal: Pediatric blood & cancer
Published: February 18, 2026
Iatrogenic Subglottic Stenosis in Mast Cell Activation Syndrome: A Sentinel Case and Narrative Review.
Journal: Ear, nose, & throat journal
Published: February 17, 2026
CRISPR/Cas9 engineered and whole-genome characterized KIT D816V-mutant human iPSC lines.
Journal: Stem cell research
Published: February 13, 2026
Hives in autonomic disorders: a cutaneous marker of a distinct symptom phenotype.
Journal: Annals of medicine
Published: February 11, 2026
Last Updated: 04/28/2026